1[1]Petersen RC,Clinic M,Rochester MN.Mild cognitive impairment:transition from aging to Alzheimer's disease.Neurobiology of Aging,2000,21(1s):s1
2[2]Haskell SG,Richardson ED,Horwitz RI,et al.The effect of estrogen replacement therapy on cognitive function in women:a critical review of the literature.J Clin Epidemiol,1997,50(11):1249
3[3]Asthana S,Craft S,Baker LD,et al.Cognitive and neuroendocrine response to transdermal estrogen in postmenopauseal women with Alzheimer's disease:results of a placebocontrolled,double-blind,pilot study.Psychoneuroendocrinology,1999,24(6):657
4[4]Baldereschi M,Di Carlo A,Lepore V,et al.Estrogen replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging.Neurology,1998,50(4):996
5[5]Kawas C,Resnick S,Morrison A,et al.A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease:the Baltimore longitudinal study of aging.Neurology,1997,48(6):1517
6[6]Reiter RJ,Carneiro RC,Oh CS.Melatonin in relation to cellular antioxidation defence mechanisms.Horn Metab Res,1997,29:363
7[7]Kotler M,Rodriquez C,Sainz R et al.Melatonin increase gene expression for antioxidant enzymes in rat brain cortex.J Pineal Res,1998,24:83
8[8]Reiter RJ,Oxidative damage in the central nervous system protection by melatonin.Prog Neurobio.1998;56:359
9[9]Li XJ,Zhang LM,Gu J,et al.Melatonin decrease production of hydroxy1 radical during ischemia-reperfusion.Acta Pharmac Sinica,1997,18:394
5[2]Lauritzen C.Clinical use of oestrogens and progestogens[J].Maturitas,1990,12(3):199
6[4]Grosgrain F,MansonJE,Stampfer MJ,et al.Postmenopausal estrogen and protesting use and the rish of cardiovascular disease[J].N Engel Med,1996,335:453～461
7[5]Ettin ger B,Friedman GB,Bush T,et al.Reduced mortality associated with long-term postmenopausal estrogen therpy[J].Obstet Gynecol,1996,87:6～12
8[8]O'Connor I F,Schemnekar M V,Shousha.Breast carcinoma developing in patients on hormone replacement therapy:a histological and immunohistological study[J].J Clin Pathol,1998,51:935～938
9[9]Beresford S A,Weiss N S,Voigt L F,et al.Rish of endometrial cancer in relation to use of estrogen combined with cyclic progentin therapy in postmenopausal women[J].Lancet,1997,349:458～461
